Serum total homocysteine, folate, 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C→T genotype and subclinical atherosclerosis

Bibliography

• Boers GH, Smals AG, Trijbels FJ, et al. Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. N Engl J Med 1985;313:709-15
   PubMed Web of Science ®Google Scholar
• Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Eng J Med 1991;324:1149-55
   PubMed Web of Science ®Google Scholar
• Lewis SJ, Ebrahim S, Smith GD. Meta-analysis of MTHFR 677C→T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate? BMJ 2005;331:1053-6
   PubMed Web of Science ®Google Scholar
• Chambless LE, Heiss G, Folsom AR, et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 1997;146:483-94
   PubMed Web of Science ®Google Scholar
• Bots ML, Hoes AW, Koudstaal PJ, et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997;96:1432-7
   PubMed Web of Science ®Google Scholar
• O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999;340:14-22
   PubMed Web of Science ®Google Scholar
• Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb 1991;11:1245-9
   PubMed Web of Science ®Google Scholar
• Ebrahim S, Papacosta O, Whincup P, et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke 1999;30:841-50
   PubMed Web of Science ®Google Scholar
• Hollander M, Bots ML, Iglesias Del Sol A, et al. Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly. The Rotterdam Study. Circulation 2002;105:2872-7
   PubMed Web of Science ®Google Scholar
• Kitamura A, Iso H, Imano H, et al. Carotid intima-media thickness and plaque characteristics as a risk factor for stroke in Japanese elderly men. Stroke 2004;35:2788-94
   PubMed Web of Science ®Google Scholar
• Kablak-Ziembicka A, Tracz W, Przewlocki T, et al. Association of increased carotid intima-media thickness with the extent of coronary artery disease. Heart 2004;90:1286-90
   PubMed Web of Science ®Google Scholar
• Ogata T, Yasaka M, Yamagishi M, et al. Atherosclerosis found on carotid ultrasonography is associated with atherosclerosis on coronary intravascular ultrasonography. J Ultrasound Med 2005;24:469-74
   PubMedGoogle Scholar
• Khoury Z, Schwartz R, Gottlieb S, et al. Relation of coronary artery disease to atherosclerotic disease in the aorta, carotid, and femoral arteries evaluated by ultrasound. Am J Cardiol 1997;80:1429-33
   PubMed Web of Science ®Google Scholar
• Hodis HN, Mack WJ, La Bree L, et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998;128:262-9
   PubMed Web of Science ®Google Scholar
• Perry IJ, Refsum H, Morris RW, et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995;346:1395-8
   PubMed Web of Science ®Google Scholar
• Griffin M, Nicolaides A, Tyllis T, et al. Carotid and femoral arterial wall changes and prevalence of clinical cardiovascular disease. Vasc Med accepted for publication, October 2008
   Google Scholar
• Ashfield-Watt PA, Pullin CH, Whiting JM, et al. Methylenetetrahydrofolate 677C→T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial. Am J Clin Nut 2002;76:180-6
   PubMed Web of Science ®Google Scholar
• Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10(1):111-3
   PubMed Web of Science ®Google Scholar
• Martin RM, Ebrahim S, Griffin M. et al. Breastfeeding and coronary atherosclerosis: intima-media thickness and plaques at 65 year follow up of the Boyd Orr Cohort. ATVB 2005;25:1-7
   Google Scholar
• Williams K, Sniderman AD, Sattar N, et al. Comparison of the associations of apolipoprotein B and low-density lipoprotein cholesterol with other cardiovascular risk factors in the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2003;108:2312-6
   PubMed Web of Science ®Google Scholar
• Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid IMT. A systematic review and meta-analysis. Circulation 2007;115:459-67
   PubMed Web of Science ®Google Scholar
• Panayiotou A, Griffin M, Georgiou N, et al. ApoB/ApoA1 ratio and subclinical atherosclerosis. Int Angiol 2008;27:74-80
   PubMed Web of Science ®Google Scholar
• Davey Smith G, Lawlor DA, Harbord R, et al. Association of C-reactive protein with blood pressure and hypertension life course confounding and Mendelian randomization tests of causality. Arterioscler Thromb Vasc Biol 2005;25:1051-6
   PubMed Web of Science ®Google Scholar
• Sundstrom J, Sullivan L, D'Agostino R, et al. Plasma homocysteine, hypertension incidence and blood pressure tracking: The Framingham Heart Study. Hypertension 2003;42:1100-5
   PubMed Web of Science ®Google Scholar
• Kanani PM, Sinkey CA, Browning RI, et al. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocyst(e)inemia in humans. Circulation 1999;100:1161-8
   PubMed Web of Science ®Google Scholar
• Stuhlinger MC, Tsao PS, Her JH, et al. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation 2001;104:2569-75
   PubMed Web of Science ®Google Scholar
• Majors A, Ehrhart LA, Pezacka EH. Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells. Arterioscler Thromb Vasc Biol 1997;17:2074-81
   PubMed Web of Science ®Google Scholar
• Voutilainen S, Alfthan G, Nyyssonen K, et al. Association between elevated plasma total homocysteine and increased common carotid artery wall thickness. Ann Med 1998;30:300-6
   PubMed Web of Science ®Google Scholar
• Malinow MR, Nieto FJ, Szklo M, et al. Carotid artery intimal-media wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study. Circulation 1993;87:1107-13
   PubMed Web of Science ®Google Scholar
• Voutilainen S, Morrow JD, Roberts LJ 2nd, et al. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb Vasc Biol 1999;19:1263-6
   PubMed Web of Science ®Google Scholar
• Soinio M, Marniemi J, Laakso M, et al. Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with Type 2 diabetes mellitus. Ann Intern Med 2004;140:94-100
   PubMed Web of Science ®Google Scholar
• McQuillan BM, Beilby JP, Nidorf M, et al. Hyperhomocysteinemia but not the 677C→T mutation of methylenetetrahudrofalate reductase is an independent risk determinant of carotid wall thicknening. The Perth Carotid Ultrasound Disease Assesement Study (CUDAS). Circulation 1999;99:2383-8
   PubMed Web of Science ®Google Scholar
• Bots ML, Launer LJ, Lindemans J, et al. Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: The Rotterdam Study. J Int Med 1997;242:339-47
   PubMed Web of Science ®Google Scholar
• Adachi H, Hirai Y, Fujiura Y, et al. Plasma homocysteine levels and atherosclerosis in Japan: Epidemiological Study by use of carotid ultrasonography. Stroke 2002;33:2177-81
   PubMed Web of Science ®Google Scholar
• Inamoto N, Katsuya T, Kokubo Y, et al. Association of methylenetetrahydrofolate reductase gene polymorphism with carotid atherosclerosis depending on smoking status in a Japanese general population. Stroke 2003;34:1628-33
   PubMed Web of Science ®Google Scholar
• Markus H, Kapozsta Z, Ditrich R, et al. Increased common carotid intima-media thickness in UK African Caribbeans and its relation to chronic inflammation and vascular candidate gene polymorphism. Stroke 2001;32:2465-71
   PubMedGoogle Scholar
• De Bree A, Mennen LI, Bertrais S, et al. Relation between homocysteine concentrations and structural and functional arterial parameters in a French general population. J Inherit Metab Disord 2003;26(Suppl):24
   Google Scholar
• Durga J, Bots ML, Schouten EG, et al. Homocysteine not associated with intima-media thickness. J Inherit Metab Disord 2003;26(Suppl):25
   PubMedGoogle Scholar
• Vermeer SE, Van Dijk EJ, Koudstaal PJ, et al. Homocysteine, silent brain infarcts and white matter lesions: The Rotterdam Scan Study. Ann Neurol 2002;51:285-9
   PubMed Web of Science ®Google Scholar
• Durga J, Verhoef P, Bots ML, Schouten E. Homocysteine and carotid intima-media thickness: a critical appraisal of the evidence. Atherosclerosis 2004;176:1-19
   PubMed Web of Science ®Google Scholar
• Gulec S, Aras O, Tutar E, et al. Methylenetetrahydrofolate reductase gene polymorphism and risk of premature myocardial infarction. Clin Cardiol 2001;24(4):281-4
   PubMed Web of Science ®Google Scholar
• Mager A, Lalezari S, Shohat T, et al. Methylenetetrahydrofolate reductase genotypes and early-onset coronary artery disease. Circulation 1999;100(24):2406-10
   PubMed Web of Science ®Google Scholar
• Inbal A, Freimark D, Modan B, et al. Sunergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males. Blood 1999;93(7):2186-90
   PubMed Web of Science ®Google Scholar
• Abu-Amero KK, Wyngaard CA, Dzimiri N. Prevalence and role of methylenetetrahydrofolate reductase 677C→T and 1298 A→C polymorphisms in coronary artery disease in Arabs. Arch Pathol Lab Med 2003;127(10):1349-52
   PubMed Web of Science ®Google Scholar
• Tokgozoglu SL, Alikasifoglu M, Unsal I, et al. Methylene tetrahydrofolate reductase genotype and the risk and extent of coronary artery disease in a population with low plasma folate. Heart 1999;81(5):518-22
   PubMed Web of Science ®Google Scholar
• Papoutsakis C, Yiannakouris N, Manios Y, et al. Plasma homocysteine concentration in Greek children are influenced by an interaction between the methylenetetrahydrofolate reductase 677C>T genotype and folate status. J Nut 2005;135:383-8
   PubMedGoogle Scholar
• Spence DJ, Malinow RM, Barnett PA, et al. Plasma homocyst(e)ine concentration, but not MTHFR genotype, is associated with variation in carotid plaque area. Stroke 1999;30:969-73
   PubMed Web of Science ®Google Scholar
• Russo GT, Friso S, Jacques PF, et al. Age and sex affect the relationship between methyltetrahydrofolate reductase C677T genotype and fasting plasma homocysteine concentrations in the Framingham Offspring Cohort Study. J Nut 2003;133:3416-21
   PubMed Web of Science ®Google Scholar
• Kauwell GPA, Lippert BL, Wilsky CE, et al. Folate status of elderly women following moderate folate depletion responds only to a higher folate intake. J Nut 2000;130:1584-90
   PubMed Web of Science ®Google Scholar
• Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death. The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 2004;291(5): 565-75
   PubMed Web of Science ®Google Scholar
• Shirodaria C, Antoniades C, Lee J, et al. Global Improvement of vascular function and redox state with low-dose folic acid: implications for folate therapy in patients with coronary artery disease. Circulation 2007;115:2262-70
   PubMed Web of Science ®Google Scholar
• Den Heijer M, Willems HP, Blom HJ, et al. Homocysteine lowering by B vitamins and the secondary prevention of deep-vein thrombosis and pulmonary embolism. A randomized, placebo-controlled, double blind trial. Blood 2007;109(1):139-44
   PubMed Web of Science ®Google Scholar
• Bonaa KH, Njolstad I, Ueland PM, et al. the NORVIT Trial Investigators, Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction. N Engl J Med 2006;354:1578-88
   PubMed Web of Science ®Google Scholar
• Ebbing M, Bleie O, Ueland PM, et al. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: A randomized controlled trial. JAMA 2008;300(7):795-804
   PubMed Web of Science ®Google Scholar
• Albert CM, Cook NR, Gaziano JM, et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: A randomized trial. JAMA 2008;299(17):2027-36
   PubMed Web of Science ®Google Scholar
• Mann JF, Sheridan P, McQueen MJ, et al. Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease – results of the renal Hope-2 study. Nephrol Dial Transplant 2008;23(2):645-53
   PubMed Web of Science ®Google Scholar
• Righetti M. Homocysteine-lowering vitamin B treatment decreases cardiovascular events in hemodialysis patients. Clin Chem Lab Med 2007;45(12):1586-9
   PubMedGoogle Scholar
• Vianna AC, Mocelin AJ, Matsuo T, et al. Uremic hyperhomocysteinemia: a randomized trial of folate treatment for the prevention of cardiovascular events. Hemodial Int 2007;11(2):210-6
   PubMedGoogle Scholar
• Tungkasereerak P, Ong-Ajyooth L, Chaiyasoot W, et al. Effect of short-term folate and vitamin B supplementation on blood homocysteine level and carotid artery wall thickness in chronic hemodialysis patients. J Med Assoc Thai 2006;89(8):1187-93
   PubMedGoogle Scholar
• Jamison RL, Hartigan P, Kaufman JS, et al. For the Veterans Affairs Site Investigators Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: A randomized controlled trial. JAMA 2007;298(10):1163-70
   PubMed Web of Science ®Google Scholar
• Spence JD, Bang H, Chambless LE, Stampfer MJ. Vitamin Intervention for Stroke Prevention Trial. An efficacy analysis. Stroke 2005;36:2404-2240
   PubMed Web of Science ®Google Scholar
• Jacques PF, Selhub J, Bostom AG, et al. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999;340(19):1449-54
   PubMed Web of Science ®Google Scholar
• Spence JD. Perspective on the efficacy analysis of the Vitamin Intervention for Stroke Prevention trial. Clin Chem Lab Med 2007;45(12):1582-5
   PubMedGoogle Scholar
• Bazzano LA, Reynolds K, Holder KN, He J. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA 2006;296(22):2720-6
   PubMed Web of Science ®Google Scholar
• Wang X, Qin X, Demirtas H, et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 2007;369(9576):1876-82
   PubMed Web of Science ®Google Scholar
• Bostom AG, Selhub J, Jacques PF, Rosenberf IH. Power shortage: Clinical trials testing the “homocysteine hypothesis”against a background of folic acid–fortified cereal grain flour. Ann Intern Med 2001;135:133-7
   PubMedGoogle Scholar